European Pharmaceutical Review

NOVEMBER 21, 2023

The pharma company stated that if successful, it has the potential to reduce greenhouse gas emissions from use of the inhaler by approximately 90 percent. Phase III trials of a low carbon version of GSK’s metered dose inhaler, Ventolin (salbutamol), using a next generation, lower carbon propellant, are set to start in 2024.

Manufacturing 116

Manufacturing Patients Pharma Leads 116

Pharmaceutical Technology

MAY 23, 2023

Generic and biosimilar firms are likely to heavily utilise this provision, and earlier market entry may lead to faster price drops for branded drugs. The resulting upheaval in launch strategies may mean that pharma can no longer depend on prioritising market launches in countries that support higher prices.

Pharma 52

Pharma Marketing Medicine Pharmaceutical 52

pharmaphorum

NOVEMBER 9, 2022

For Sanofi, the agreement marks a further embracing of AI in its drug discovery operations, which has previously seen the pharma strike a $270 million partnership deals with Owkin to find new cancer therapies, and a massive $5.2 Its lead indication is idiopathic pulmonary fibrosis. The Pharma.AI The Pharma.AI

Pharma 102

Pharma Leads Marketing Medicine 102

PM360

OCTOBER 25, 2023

At the heart of this transformation is the role of medical affairs, which is undergoing something of a rebrand as it moves from supporting function to strategic partner within the broader pharma organization. Pharma’s Data Dichotomy Without a doubt, pharma’s primary mission is to create and provide treatments for patients.

Management 105

Management Medical Pharma Pharmaceutical 105

PM360

OCTOBER 8, 2024

First of its kind, in-office, digital hub enhances provider efficiency and care team collaboration Cincinnati, Ohio – October 7, 2024 – PatientPoint® a leading digital health company, today showcased the transformation of its healthcare professional solution with the launch of an interactive, in-office digital hub.

Healthcare Provider 52

Healthcare Provider Pharma reps Pharma Rep Physicians 52

European Pharmaceutical Review

NOVEMBER 23, 2023

For example, CPI asserted that lead times for clinical trial materials are hindering new therapies being developed. This is a first-of-its-kind collaboration for the pharma industry. CPI confirmed that the centre will establish operations during 2024 and be finished in late 2025.

Manufacturing 104

Manufacturing Medicine Government Pharmaceutical 104

European Pharmaceutical Review

SEPTEMBER 26, 2022

The €60 million expansion will open 70 new jobs in sterile manufacturing, quality control and engineering in 2025. Earlier this year, AbbVie was named Best Workplace for Women and ‘Biopharma Company of the Year’ at the latest Irish Pharma Industry Awards. Construction at the Carrigtwohill facility built in 2013 is set to begin in 2023.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 98

Pharmaceutical Technology

SEPTEMBER 5, 2022

Until 2025, we have strong growth ahead of us, but we also believe we can continue to grow very strongly post-2025 and it’s all about innovation in the pipeline.”. On 23 August, at a Reuters Newsmakers online forum, Soriot announced his interest in increasing AstraZeneca’s portfolio of bolt-on acquisitions leading up to 2025.

FDA 114

FDA Pharmaceutical Biopharma Pharma 114

pharmaphorum

AUGUST 17, 2022

The deal will see Atomwise identify, synthesize, and advance lead compounds for up to five drug targets that will then be exclusively Sanofi’s to develop. It’s part of a larger trend of big pharmas hedging their bets with partnerships with AI firms to find more drug candidates faster.

Medicine 78

Medicine Pharma Engineering Sales 78

Clarivate

AUGUST 7, 2024

OptumRx Clear Trend Guarantee (effective from January, 2025) Value-based care model; Combines guarantee and consolidates costs for retail pharmacy, home delivery, specialty drugs, and rebates into a single per-member cost. The pricing estimates are not guaranteed, leading to potential unexpected expenses.

Retail 59

Retail Marketing Competition Biopharma 59

Penrod

JUNE 6, 2024

To some extent, this patient model fits the requirements of med dev and pharma pretty well, but it wasn’t one-size-fits-all. The main features aim to improve how med dev and pharma companies conduct commercial and clinical operations. What use cases will Life Sciences Cloud Solve?

CRM 52

CRM Food and Drug Administration Healthcare Provider Management 52

pharmaphorum

NOVEMBER 1, 2022

billion by 2025, growing at a CAGR of 7.5%. Benefits of attending: Explore how mRNA leads the way in the genetic medicine space as the next generation of novel drug modalities. Enhance your knowledge of the latest innovations in RNA application and RNA delivery techniques with case studies from BioNTech, Neuway Pharma and Ethris GmbH.

Medicine 52

Medicine Pharmacology Networking Pharma 52

Pharmaceutical Technology

JANUARY 19, 2023

Antigens such as CD123 and CD33, despite being markers of myeloid cells, are shared with their healthy counterparts, and myeloablation following their depletion often leads to detrimental clinical outcomes. GlobalData’s Pharma Intelligence Center shows 19 autologous CAR-T cell products in Phase I, and nine products in Phase II, globally.

Marketing 52

Marketing FDA Sales Management 52

Clarivate

MAY 13, 2024

After staying relatively flat for several years, enrollment growth took off in 2021 after an expansion in federal subsidies for silver-level plans passed in the American Rescue Plan and was then renewed through 2025 in the Inflation Reduction Act. Pillo, Senior Healthcare Research and Data Analyst. The post The U.S.

Insurance 52

Insurance Marketing Healthcare Healthcare 52

pharmaphorum

JULY 22, 2022

Co-Chaired by: Conor Murray, Chairman, Irish Cleanroom Society and Connor McMorrow, Aseptic Lead Cell Therapy, Takeda. Advances in Pharma 4.0 In 2025, the global cleanroom technology market is expected to reach nearly $5 billion. Sponsored by Ecolab, Elis Cleanroom, Innerspace, Microgenetics, Novatek.

Pharmaceutical 52

Pharmaceutical Management Engineering Media 52

pharmaphorum

OCTOBER 12, 2022

The research collaboration will explore the use of the two companies’ technologies side by side to find targets across a range of human diseases for an initial six-month period, and if successful could lead to a long term, strategic level partnership, according to the partners.

Pharma 64

Pharma Training Networking Leads 64

PM360

JUNE 29, 2022

By 2025, sales of consumer health products are expected to reach $368bn, according to Euromonitor, encompassing everything from sleep aids to vitamins to sports nutrition products. Healthcare and pharma companies are watching this trend and refining their strategies to meet tomorrow’s health consumer.

Retail 97

Retail Marketing Healthcare Healthcare 97

European Pharmaceutical Review

SEPTEMBER 28, 2023

Known as MITC, or the Moderna Innovation and Technology Centre, the facility is located in Harwell, Oxfordshire and is expected to become operational in 2025. Chornet highlighted one of the biggest challenges in pharma currently: “everybody is looking for alternatives for supply chain.

Manufacturing 98

Manufacturing Government Pharmaceutical manufacturing Pharmaceutical 98

pharmaphorum

SEPTEMBER 22, 2022

With a reorganisation of Novartis now nearing completion, the Swiss pharma group is laying out its plans for growth at a meeting with investors and analysts, which it says will be driven mainly by five drugs. The post Revamped Novartis highlights top R&D programmes at management update appeared first on.

Management 52

Management Sales Patients Marketing 52

PM360

AUGUST 26, 2024

Fortune 500s or Start-Ups; what are the opportunities and challenges for top school business graduates to consider for the Healthcare/Pharma/Biotech vertical? A: (Galeota) MIT Sloan’s and all MIT students should consider the tremendous career opportunities that the Healthcare/Pharma/Biotech vertical offers.

Distribution 52

Distribution Biopharma Healthcare Healthcare 52

Pharmaceutical Technology

JANUARY 8, 2023

Today, approximately 384 million people around the globe have COPD and it is the third leading cause of death worldwide, the Global Initiative for Chronic Obstructive Lung Disease reports. While the pharmaceutical landscape for asthma has several approved biologics, in stark contrast, the COPD environment has zero biologic approvals.

Patients 119

Patients FDA Pharmaceutical Pharma 119

European Pharmaceutical Review

APRIL 30, 2024

VG: I think that in 2024 macroeconomic factors will continue to influence the market: in particular high interest rates which continue to lead sponsor companies to slow down their collaboration with CDMOs. For example, they will continue to mainly focus on one lead candidate, instead of working on multiple molecules in their pipeline.

Manufacturing 97

Manufacturing Food and Drug Administration Biopharma Marketing 97

Clarify Health

JULY 13, 2020

The panel included Bhash Parasuraman, PhD, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer , Calum MacRae, MD, PhD, Professor of Medicine at Harvard Medical School , and Surya Singh, MD, President, Singh Healthcare Advisors. By 2025, several new gene and cell therapies will be coming to market.

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. A recent Science 37 survey noted that nearly three-quarters (73%) of respondents from the pharma industry were planning a hybrid or DCT, up from 49% in 2021. Novel digital endpoints. Source: Landers et al.,

Pharma 76

Pharma Patients FDA Marketing 76

pharmaphorum

AUGUST 9, 2022

Cancer is the second leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, according to the World Health Organization. AI could address the most significant issue in drug discovery, finds Ben Hargreaves, and also offers the potential to use tissue samples to create precision medicine for specific patient groups.

Doctors 97

Doctors Patients Medicine Pharma 97

Impetus Digital

APRIL 24, 2023

A Vision for Medical Affairs In A Vision for Medical Affairs in 2025 –a recent McKinsey & Company report–the authors provided thought-provoking insights into the evolution of MA, mirroring what we have been hearing first-hand. Nevertheless, some Pharma executives have been resistant to wholly embracing digital transformation.

Medical 52

Medical Education Physicians Healthcare 52

Clarivate

APRIL 24, 2023

These developments, together with Walgreens’ recent rollout of Health Corners that help patients manage chronic conditions and its October 2022 announcement that it would fully acquire CareCentrix (a platform that coordinates post-acute and home care), underscore Walgreens’ plans to become a leading healthcare provider. The post U.S.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Eversana Intouch

SEPTEMBER 27, 2024

Here are a few of the things we learned and some associated implications heading into 2025. And this is where the real conversations were happening – where pharma was actually asking oncologists about how trials should be conducted, soliciting their opinion and direction. EVERSANA was there with teams from across the U.S.

Patients 59

Patients Medical Healthcare Healthcare 59

PM360

AUGUST 9, 2022

This new world order is marked by smaller, fragmented opportunities, increasing headwinds in high investment therapeutic areas, more complex customer groups requiring nuanced engagement models, and more compressed resources and investment from global pharma. Expectations Are Increasing for Global Access to Therapies.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

pharmaphorum

OCTOBER 12, 2022

Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. By 2025, pharma’s investment in AI is expected to reach $3 billion. About Debiopharm Innovation Fund.

Medicine 92

Medicine Patients Healthcare Healthcare 92

Clarivate

APRIL 18, 2024

In 2023, Humana’s care delivery component CenterWell launched a senior-centered “ Primary Care Anywhere ” program for in-home primary care in Georgia and Louisiana (where Humana leads the MA sectors) and increased senior membership in value-based home care models nationwide to more than 840,000.

Retail 52

Retail Healthcare Healthcare Physicians 52

pharmaphorum

NOVEMBER 25, 2022

The Parma site, as yet only nine months into construction, is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. In brief, the European plan for Chiesi is in-house drug development of biologicals and rare disease targeting. Going beyond the standards of care; improving drug safety and efficacy.

Pharmaceutical 94

Pharmaceutical Manufacturing Medicine Competition 94

Healthcare Success

NOVEMBER 7, 2022

According to Axios, traditional pay-TV providers like Comcast, Verizon, and Dish Network have lost a staggering 25 million subscribers since 2012 and are expected to lose another 25 million by 2025. For example, pharma marketers can track and attribute increased prescriptions to specific ad campaigns. Your ads should be streaming, too.

Marketing 52

Marketing Media Healthcare Healthcare 52

Celeritas

NOVEMBER 7, 2022

billion by 2025. High-value AI-driven drones and equipment can harvest inputs with greater accuracy, leading to higher productivity and a significant drop in expenditure. Automated cleaning systems improve hygiene to lower the risk of infection and facilitate the ease of access for waste removal machinery. Heightened Profitability.

Networking 52

Networking Pharmaceutical products Management Transportation 52

Evolve Your Success

NOVEMBER 28, 2023

He is a fellow podcaster with interviews from notable university professors leading researchers and fourth-thinking podcast hosts. It’s nice to be able to speak with guests that have had been long enough in this space that they now are in a position to be part of something new and game-changing or lead something new and game-changing.

Medical 52

Medical Medical sales Sales Patients 52

Clarivate

OCTOBER 10, 2022

Nevertheless, the anticipated entry of pertuzumab biosimilars in 2025 and the reimbursement status for both brands on NRDL in this patient segment is likely to influence first-line uptake of pyrotinib in Mainland China. Learn more about our healthcare market intelligence solutions.

Marketing 52

Marketing Safety Patients Competition 52

pharmaphorum

DECEMBER 6, 2022

Genetic testing companies, such as 23andMe , provide a service to check consumers’ genetic background, whilst also using the data gathered to collaborate with pharma companies on potential treatments. It is estimated that this will reach 70% by 2035. Industry interest. This makes it difficult to diagnose MS early.

Recruitment 89

Recruitment Pharma Patients Healthcare 89